[HTML][HTML] Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a …
T Shi, DA McAllister, KL O'Brien, EAF Simoes… - The Lancet, 2017 - thelancet.com
Background We have previously estimated that respiratory syncytial virus (RSV) was
associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) …
associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) …
After asthma: redefining airways diseases
Executive summary Asthma is responsible for considerable global morbidity and health-care
costs. Substantial progress was made against key outcomes such as hospital admissions …
costs. Substantial progress was made against key outcomes such as hospital admissions …
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
Respiratory syncytial virus is the second most common cause of infant mortality and a major
cause of morbidity and mortality in older adults (aged> 60 years). Efforts to develop a …
cause of morbidity and mortality in older adults (aged> 60 years). Efforts to develop a …
Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants
B Kampmann, SA Madhi, I Munjal… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …
[HTML][HTML] Nirsevimab for prevention of RSV in healthy late-preterm and term infants
LL Hammitt, R Dagan, Y Yuan… - … England Journal of …, 2022 - Mass Medical Soc
Background Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract
infection and hospitalization in infants. Nirsevimab is a monoclonal antibody to the RSV …
infection and hospitalization in infants. Nirsevimab is a monoclonal antibody to the RSV …
[HTML][HTML] Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years …
Background Respiratory syncytial virus (RSV) is the most common cause of acute lower
respiratory infection in young children. We previously estimated that in 2015, 33· 1 million …
respiratory infection in young children. We previously estimated that in 2015, 33· 1 million …
Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study
HJ Zar, D Hanslo, P Apolles, G Swingler, G Hussey - The Lancet, 2005 - thelancet.com
Background For microbiological confirmation of diagnosis of pulmonary tuberculosis in
young children, sequential gastric lavages are recommended; sputum induction has not …
young children, sequential gastric lavages are recommended; sputum induction has not …
Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8.
E DiMango, HJ Zar, R Bryan… - The Journal of clinical …, 1995 - Am Soc Clin Investig
Respiratory epithelial cells play a crucial role in the inflammatory response during
Pseudomonas aeruginosa infection in the lungs of patients with cystic fibrosis. In this study …
Pseudomonas aeruginosa infection in the lungs of patients with cystic fibrosis. In this study …
Improving lung health in low-income and middle-income countries: from challenges to solutions
Low-income and middle-income countries (LMICs) bear a disproportionately high burden of
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …
[HTML][HTML] Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study
MP Nicol, L Workman, W Isaacs, J Munro… - The Lancet infectious …, 2011 - thelancet.com
Background WHO recommends that Xpert MTB/RIF replaces smear microscopy for initial
diagnosis of suspected HIV-associated tuberculosis or multidrug-resistant pulmonary …
diagnosis of suspected HIV-associated tuberculosis or multidrug-resistant pulmonary …